Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Leukemia × Introns × Clear all

Phase

Phase 2 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Triple Negative Breast Neoplasms 1 Leukemia 1

Interventions

fludarabine 1 Transplantation 1 Tablets 1 Stem Cell Transplantation 1 Roflumilast 1 Pemetrexed 1 Nadolol 1 Isoproterenol 1 Introns 1 FANG vaccine 1 Exercise 1 Cyclophosphamide 1 Counseling 1 Cord Blood Stem Cell Transplantation 1 Carvedilol 1 Bortezomib 1 Bisoprolol 1 68Ga-pentixafor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02331706 2020-04-21

IFN-DLI for Relapsed Acute Leukemia After Allo-SCT

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed

Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡